CARLOS
TAXONERA SAMSO
Profesor asociado de Ciencias de la Salud
Pharmacoeconomics and Outcomes Research Iberia
Pozuelo de Alarcón, EspañaPublicaciones en colaboración con investigadores/as de Pharmacoeconomics and Outcomes Research Iberia (2)
2022
-
Cost-effectiveness analysis of using innovative therapies for the management of moderate-to-severe ulcerative colitis in Spain
Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 22, Núm. 1, pp. 73-83
2009
-
Infliximab maintenance therapy is associated with decreases in direct resource use in patients with luminal or fistulizing crohn's disease
Journal of Clinical Gastroenterology, Vol. 43, Núm. 10, pp. 950-956